Intermittent high dose scheduling of AZD8835, a novel...

  • Main
  • 2016 / 02
  • Intermittent high dose scheduling of AZD8835, a novel...
Molecular Cancer Therapeutics 2016 / 02

Intermittent high dose scheduling of AZD8835, a novel selective inhibitor of PI3K  and PI3K , demonstrates treatment strategies for PIK3CA-dependent breast cancers

Hudson, K., Hancox, U. J., Trigwell, C., McEwen, R., Polanska, U. M., Nikolaou, M., Morentin Gutierrez, P., Avivar-Valderas, A., Delpuech, O., Dudley, P., Hanson, L., Ellston, R., Jones, A., Cumberbat
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-15-0687
Date:
February, 2016
File:
PDF, 1.23 MB
english, 2016
Conversion to is in progress
Conversion to is failed